J. Meireles-Brandao/LinkedIn
Aug 3, 2026, 11:37
J. Meireles-Brandao: The Immunological Face of Atherosclerosis
J. Meireles-Brandao, Associate at SEDES – Association for Economic and Social Development, shared a post on LinkedIn:
“Immunology, Inflammation, Macrophages… LDLc, TC, TGRL, RC, MVR, ApoB, IL-6
- beyond Cholesterol and in the context of Lipoprotein Disease.
Reducing inflammatory markers is important, but it doesn’t immediately translate into fewer events.
Inflammation is a consequence, addressing the cause is crucial.”
Stay updated with Hemostasis Today.
-
Aug 3, 2026, 12:44Replaying the CSL Symposium on Gene Therapy Durability in Haemophilia – EAHAD
-
Aug 3, 2026, 12:43Shinta C: Takeda Marks a Milestone in Hemophilia Care
-
Aug 3, 2026, 12:37Deepak Kumar Dasmohapatra: Honored for Contributions to Transfusion Medicine and Immunohematology by the Governor of Chhattisgarh
-
Aug 3, 2026, 12:30Furkan Bahar: Thrombotic and Hemorrhagic Risk Profiles in Advanced Melanoma – Targeted vs Immune Combination Therapies
-
Aug 3, 2026, 12:28Tayyaba Iftikhar: When Platelets Talk to Cancer Cells
-
Aug 3, 2026, 12:19Heparin Beyond Anticoagulation in Sepsis – JTH
-
Aug 3, 2026, 12:14Yaqui Valenzuela: Hemophilia Care Evolves Beyond Factor Replacement
-
Aug 3, 2026, 12:12José Antonio García Erce: Which Oral Iron Therapy Should We Choose?
-
Aug 3, 2026, 11:59Flora Peyvandi: Roctavian Withdrawal Signals Adoption Challenges